RE:There was no reasonHey Stocksandbonds, I agree, the data presented today is mostly positive, lacking in clarity. I wish they can separate the patients who received ideal dosage from the initial group of patients who received less than ideal dosage. I am more impressed with the consistency and durability over 365+ Days, as well as safety with little or no adverse effects directly attributable to the treatment. For now, I am grossly over weighted on TLT, going to stay away from all Bull Boards, make sure I don't get carried away and buy more!!